Biopsy Devices Market

The global market for biopsy products is being driven by the increasing incidence of cancer, of which there are over 14 million new cases each year.  This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the worldwide biopsy devices market, which includes biopsy guidance systems, needle-based biopsy products, and other biopsy devices (forceps, curettes, punch and shave biopsy devices). Global biopsy device sales are projected to expand at a compound annual growth rate (CAGR) of 6.7% during 2016-21, increasing from approximately $1,649.0m in 2016 to an estimated $2,277.3m in 2021. Countries/regions covered by this report include the US, five major European markets (France, Germany, Italy, Spain, and the UK), Japan, and the Rest of the World segment (which combines estimated sales data for all other countries).